Literature DB >> 8191217

Decreased CD8-p56lck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis.

F A Arosa1, A J da Silva, I M Godinho, J C ter Steege, G Porto, C E Rudd, M de Sousa.   

Abstract

Hereditary haemochromatosis (HH) is an autosomal recessive disease linked to certain MHC class-I specificities. The disease is characterized by increased iron absorption and, in some patients, abnormally low numbers of CD8+ T cells in the periphery. We were interested in whether CD4- and CD8-associated p56lck kinase activities were altered in patients with HH. In a study of 18 patients with HH (with and without low numbers of CD8+ cells), the level of autophosphorylation of the CD8-associated p56lck as well as its phosphotransferase activity, as determined by phosphorylation of an exogenous substrate, was significantly reduced by two- to three-fold relative to a control population of 23 healthy blood donors (P < 6 x 10(-7). CD8-p56lck activity was decreased in 16 out of 18 patients (ranging from 1.5- to 10-fold decrease). By contrast, the level of CD4-p56lck activity did not show an overall decrease relative to controls. In addition to an occasional decrease in the amount of CD8-associated lck, HH patient-derived T cells showed a consistent decrease in the relative CD8-p56lck specific activity. Immunofluorescence staining showed further that the difference could not be accounted by a discrepancy in the expression of CD8 alpha alpha or CD8 alpha beta complexes or MHC class I molecules. Decreased CD8-p56lck activity was seen both in patients undergoing intensive phlebotomy treatment and in patients in maintenance therapy (i.e. patients who had reached normal levels of iron stores), indicating that this abnormality does not appear to be corrected by iron depletion. To our knowledge, this is the first demonstration of an abnormality in a src-like receptor associated kinase in a human disease state linked to MHC class-I antigens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8191217     DOI: 10.1111/j.1365-3083.1994.tb03396.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  13 in total

Review 1.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells.

Authors:  M F Macedo; G Porto; M Costa; C P Vieira; B Rocha; E Cruz
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

3.  Heme oxygenase 1 is required for mammalian iron reutilization.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy.

Authors:  N G Mahon; A S Coonar; S Jeffery; F Coccolo; J Akiyu; B Zal; R Houlston; G E Levin; C Baboonian; W J McKenna
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 5.  Iron overload and immunity.

Authors:  Graça Porto; Maria De Sousa
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

6.  Lymphocyte subsets in alcoholic liver disease.

Authors:  Luís Costa Matos; Paulo Batista; Nuno Monteiro; João Ribeiro; Maria A Cipriano; Pedro Henriques; Fernando Girão; Armando Carvalho
Journal:  World J Hepatol       Date:  2013-02-27

7.  ER Stress and Iron Homeostasis: A New Frontier for the UPR.

Authors:  Susana J Oliveira; Maria de Sousa; Jorge P Pinto
Journal:  Biochem Res Int       Date:  2010-12-20

8.  Physiological implications of NTBI uptake by T lymphocytes.

Authors:  Jorge P Pinto; João Arezes; Vera Dias; Susana Oliveira; Inês Vieira; Mónica Costa; Matthijn Vos; Anna Carlsson; Yuri Rikers; Maria Rangel; Graça Porto
Journal:  Front Pharmacol       Date:  2014-02-26       Impact factor: 5.810

9.  On myocardial siderosis and left ventricular dysfunction in hemochromatosis.

Authors:  John-Paul Carpenter; Agata E Grasso; John B Porter; Farrukh Shah; James Dooley; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2013-03-19       Impact factor: 5.364

Review 10.  The unfolded protein response in hereditary haemochromatosis.

Authors:  S F de Almeida; M de Sousa
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.